Park Ha Biological Technology Co., Ltd. (BYAH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 10-31. Amounts in USD.

Revenue Annual

0 900K 1.8M 2.7M FY22: 1.9M FY23: 2.5M FY24: 2.4M FY25: 2.5M FY22 FY23 FY24 FY25

Gross Profit Annual

0 900K 1.8M 2.7M FY22: 1.4M FY23: 2.1M FY24: 2.2M FY25: 2.4M FY22 FY23 FY24 FY25

Operating Income Annual

-27M -18M -9M 0 9M 18M 27M FY22: 197K FY23: 1.2M FY24: 793.7K FY25: -24.1M FY22 FY23 FY24 FY25

Net Income Annual

-27M -18M -9M 0 9M 18M 27M FY22: 191.3K FY23: 852K FY24: 478.6K FY25: -24.4M FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 200K 400K 600K FY22: 509.2K FY23: 311K FY24: 195.3K FY25: 142.5K FY22 FY23 FY24 FY25

Operating Cash Flow Annual

0 500K 1M 1.5M FY22: 1.4M FY23: 126.5K FY24: 960.5K FY25: 85.9K FY22 FY23 FY24 FY25

Free Cash Flow Annual

-500K 0 500K 1M 1.5M FY22: 1.4M FY23: 103.9K FY24: 874.9K FY25: -3K FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 9M 18M 27M FY22: 25M FY23: 500K FY24: 500K FY25: 588.9K FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.